Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pravastatin histone deacetylase 2 small molecule NA drugbank Serum[MeSHID:D044967]
Cardiovascular Diseases[MeSHID:D002318]
Arteriosclerosis[MeSHID:D001161]
Myocardial Infarction[MeSHID:D009203]
Transient Cerebral Ischemia[MeSHID:D002546]
Disease Progression[MeSHID:D018450]
Dyslipidemias[MeSHID:D050171]
Hypertriglyceridemia[MeSHID:D015228]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Blood[MeSHID:D001769]
Plasma[MeSHID:D010949]
Cerebrovascular accident[MeSHID:D020521]
Cardiac Death[MeSHID:D003643]
Premature Birth[MeSHID:D047928]
Heart[MeSHID:D006321]
Atherosclerosis[MeSHID:D050197]
Heterozygote[MeSHID:D006579]
Term Birth[MeSHID:D047929]
Coronary Arteriosclerosis[MeSHID:D003324]
Hypercholesterolemia
Familial[MeSHID:D006938]
Disease[MeSHID:D004194]
Myocardium[MeSHID:D009206]
Hyperlipoproteinemia Type IV[MeSHID:D006953]
Hyperlipoproteinemia Type III[MeSHID:D006952]
Risk Reduction[MeSHID:D040242]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
pravastatin hmg-coa reductase NA Successful target TTD , DGIDB Serum[MeSHID:D044967]
Cardiovascular Diseases[MeSHID:D002318]
Arteriosclerosis[MeSHID:D001161]
Myocardial Infarction[MeSHID:D009203]
Transient Cerebral Ischemia[MeSHID:D002546]
Disease Progression[MeSHID:D018450]
Dyslipidemias[MeSHID:D050171]
Hypertriglyceridemia[MeSHID:D015228]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Blood[MeSHID:D001769]
Plasma[MeSHID:D010949]
Cerebrovascular accident[MeSHID:D020521]
Cardiac Death[MeSHID:D003643]
Premature Birth[MeSHID:D047928]
Heart[MeSHID:D006321]
Atherosclerosis[MeSHID:D050197]
Heterozygote[MeSHID:D006579]
Term Birth[MeSHID:D047929]
Coronary Arteriosclerosis[MeSHID:D003324]
Hypercholesterolemia
Familial[MeSHID:D006938]
Disease[MeSHID:D004194]
Myocardium[MeSHID:D009206]
Hyperlipoproteinemia Type IV[MeSHID:D006953]
Hyperlipoproteinemia Type III[MeSHID:D006952]
Risk Reduction[MeSHID:D040242]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.27 approved unknown
pravastatin 3-hydroxy-3-methylglutaryl-coenzyme a reductase small molecule NA drugbank , DGIDB Serum[MeSHID:D044967]
Cardiovascular Diseases[MeSHID:D002318]
Arteriosclerosis[MeSHID:D001161]
Myocardial Infarction[MeSHID:D009203]
Transient Cerebral Ischemia[MeSHID:D002546]
Disease Progression[MeSHID:D018450]
Dyslipidemias[MeSHID:D050171]
Hypertriglyceridemia[MeSHID:D015228]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Blood[MeSHID:D001769]
Plasma[MeSHID:D010949]
Cerebrovascular accident[MeSHID:D020521]
Cardiac Death[MeSHID:D003643]
Premature Birth[MeSHID:D047928]
Heart[MeSHID:D006321]
Atherosclerosis[MeSHID:D050197]
Heterozygote[MeSHID:D006579]
Term Birth[MeSHID:D047929]
Coronary Arteriosclerosis[MeSHID:D003324]
Hypercholesterolemia
Familial[MeSHID:D006938]
Disease[MeSHID:D004194]
Myocardium[MeSHID:D009206]
Hyperlipoproteinemia Type IV[MeSHID:D006953]
Hyperlipoproteinemia Type III[MeSHID:D006952]
Risk Reduction[MeSHID:D040242]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.27 approved inhibitor
pravastatin hmg-coa reductase NA Successful target TTD , DGIDB Serum[MeSHID:D044967]
Cardiovascular Diseases[MeSHID:D002318]
Arteriosclerosis[MeSHID:D001161]
Myocardial Infarction[MeSHID:D009203]
Transient Cerebral Ischemia[MeSHID:D002546]
Disease Progression[MeSHID:D018450]
Dyslipidemias[MeSHID:D050171]
Hypertriglyceridemia[MeSHID:D015228]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Blood[MeSHID:D001769]
Plasma[MeSHID:D010949]
Cerebrovascular accident[MeSHID:D020521]
Cardiac Death[MeSHID:D003643]
Premature Birth[MeSHID:D047928]
Heart[MeSHID:D006321]
Atherosclerosis[MeSHID:D050197]
Heterozygote[MeSHID:D006579]
Term Birth[MeSHID:D047929]
Coronary Arteriosclerosis[MeSHID:D003324]
Hypercholesterolemia
Familial[MeSHID:D006938]
Disease[MeSHID:D004194]
Myocardium[MeSHID:D009206]
Hyperlipoproteinemia Type IV[MeSHID:D006953]
Hyperlipoproteinemia Type III[MeSHID:D006952]
Risk Reduction[MeSHID:D040242]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.27 approved inhibitor
click here to return to the previous page